Table 7.
Study 2 (Sudan): sero-positivity of the four rK28 RDTs to serum panels from different Sudanese patient groups and controls*
| Serum panels | DAT | DPP | CTK | EMT | InBios+ |
|---|---|---|---|---|---|
| Number positive/number tested (% positive) | |||||
| VL | 95/100 (95.0) | 95/100 (95.0) | 94/100 (94.0) | 97/100 (97.0) | 96/100 (96.0) |
| Healthy, endemic controls | 0/25 (0.0) | 2/25 (8.0) | 0/25 (0.0) | 3/25 (12.0) | 3/22 (12.0) |
| Healthy, non-endemic controls | 0/50 (0.0) | 0/50 (0.0) | 0/50 (0.0) | 2/50 (4.1) | 1/50 (2.0) |
| Malaria | 0/25 (0.0) | 1/25 (4.0) | 0/25 (0.0) | 4/25 (16.0) | 4/25 (16.0) |
| Pulmonary TB | 0/25 (0.0) | 0/25 (0.0) | 0/25 (0.0) | 1/25 (4.0) | 1/25 (4.0) |
| Intestinal schistosomiasis | 0/25 (0.0) | 3/25 (12.0) | 1/25 (4.0) | 3/25 (12.0) | 2/25 (8.0) |
*
RDTs = rapid diagnostic tests; DAT = direct agglutination test; DPP = dual path platform; EMT = EASE-Medtrend test; VL = visceral leishmaniasis.